Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Rocket Pharmaceuticals, Inc.

NASDAQ: RCKT · Life Sciences · 6 alerts · CIK 1281895

Share price
$2.16Close, Nov 16
Market cap
$241M
Shares outstanding
111.66MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Rocket Pharmaceuticals, Inc. filings on SEC EDGAR ↗

5:16 PM ET 8-K
Loan & Debt

Rocket Pharmaceuticals $150M Debt Financing with Hercules Capital, Inc.

Rocket Pharmaceuticals entered into a senior secured term loan agreement with Hercules Capital for up to $150.0 million across five tranches. The company received an initial $35.0 million at closing, with subsequent tranches available upon clinical milestones and lender approval to support its Phase 2 study of RP-A501 for Danon disease.

Value
$150M
Counterparty
Hercules Capital, Inc.
Term
Through Oct 2030

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.